5R42AG062095-03 |
2020 |
$631965 |
Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate |
NEUROKINE THERAPEUTICS, LLC |
4R42AG062095-02 |
2019 |
$2018653 |
Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate |
NEUROKINE THERAPEUTICS, LLC |
1R42AG062095-01 |
2018 |
$504907 |
Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate |
Neurokine Therapeutics LLC |